Vasodilator effect of nicorandil on retinal blood vessels in rats

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 375, Issue 5, 2007, Pages 323-328

  Ogawa, Naoto ^a   Saito, Maki ^a   Mori, Asami ^a   Sakamoto, Kenji ^a   Kametaka, Sokichi ^a   Nakahara, Tsutomu ^a   Ishii, Kunio ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

KATP channel; Nicorandil; Nitric oxide (NO); Prostaglandins; Retinal blood vessel

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; INDOMETACIN; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PINACIDIL; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE INHIBITOR; THIOBUTABARBITAL;

ANESTHESIA; ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CAMERA; CONTROLLED STUDY; DEPRESSOR RESPONSE; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; IN VIVO STUDY; INHIBITION KINETICS; LOW DRUG DOSE; MALE; NONHUMAN; OPHTHALMOSCOPY; RAT; RETINA ARTERY; RETINA BLOOD VESSEL; VASODILATATION; WISTAR RAT;

ANALYSIS OF VARIANCE; ANIMALS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYBURIDE; INDOMETHACIN; MALE; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROPRUSSIDE; PINACIDIL; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; RETINAL VESSELS; VASODILATION; VASODILATOR AGENTS;

EID: 34250680571     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0165-7     Document Type: Article

References (24)

1. Akai K, Wang Y, Sato K, Sekiguchi N, Sugimura A, Kumagai T, Komaru T, Kanatsuka H, Shirato K (1995) Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels. J Cardiovasc Pharmacol 26:541-547
2. + channel opening and guanylate cyclase stimulation to its vasorelaxant effects on various endothelin-1-contracted arterial preparations. Comparison to aprikalim (RP 52891) and nitroglycerin. J Pharmacol Exp Ther 259:526-534
3. Cavero I, Mondot S, Mestre M (1989) Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 248:1261-1268
4. Chemtob S, Beharry K, Rex J, Chatterjee T, Varma DR, Aranda JV (1991) Ibuprofen enhances retinal and choroidal blood flow autoregulation in newborn piglets. Invest Ophthalmol Vis Sci 32:1799-1807
5. Cicala C, Pinto A, Bucci M, Sorrentino R, Walker B, Harriot P, Cruchley A, Kapas S, Howells GL, Cirino G (1999) Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation 99:2590-2597
6. ATP channels mediate adenosine-induced hyperemia in retina. Invest Ophthalmol Vis Sci 37:2624-2633
7. Gollasch M, Bychkov R, Ried C, Behrendt F, Scholze S, Luft FC, Haller H (1995) Pinacidil relaxes porcine and human coronary arteries by activating ATP-dependent potassium channels in smooth muscle cells. J Pharmacol Exp Ther 275:681-692
8. Frampton J, Buckley MM, Fitton A (1992) Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 44:625-655
9. Furukawa K, Itoh T, Kajiwara M, Kitamura K, Suzuki H, Ito Y, Kuriyama H (1981) Vasodilating actions of 2-nicotinamidoethyl nitrate on porcine and guinea-pig coronary arteries. J Pharmacol Exp Ther 218:248-259
10. Hardy P, Abran D, Hou X, Lahaie I, Peri KG, Asselin P, Varma DR, Chemtob S (1998) A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ Res 83:721-729
11. 2A receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels. J Pharmacol Exp Ther 291:655-664
12. ATP channels in retinal arteriolar dilation in response to adenosine. Invest Ophthalmol Vis Sci 46:2113-2119
13. Kaneko Y, Saito M, Mori A, Sakamoto K, Nakahara T, Ishii, K (2006) Vasodilator effects of adrenomedullin on retinal arterioles in streptozotocin-induced diabetic rats. J Ocular Pharmacol Ther 22:317-322
14. Kinoshita M, Sakai K (1990) Pharmacology and therapeutic effects of nicorandil. Cardiovasc Drugs Ther 4:1075-1088
15. Kukovetz WR, Holzmann S, Braida C, Poch G (1991) Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J Cardiovasc Pharmacol 17:627-633
16. + channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen. J Pharmacol Exp Ther 268:1411-1418
17. + channels in the relaxant response of dog middle cerebral artery to cromakalim. J Pharmacol Exp Ther 255:818-825
18. Nakazawa T, Kaneko Y, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K (2007) Attenuation of nitric oxide- and prostaglandin-independent vasodilation of retinal arterioles induced by acetylcholine in streptozotocin-treated rats. Vasc Pharmacol 46:153-159
19. + channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways. Br J Pharmacol 123:847-854
20. Riva CE, Sinclair SH, Grunwald JE (1981) Autoregulation of retinal circulation in response to decrease of perfusion pressure. Invest Ophthalmol Vis Sci 21:34-38
21. Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH (1986) Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 27:722-726
22. ATP channels. Jpn J Pharmacol 79:51-57
23. Taira N (1989) Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol 63:18J-24J
24. 2 contributes to the vasodepressor effect of baicalein in hypertensive rats. Hypertension 31:866-871